Trial Profile
Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Oct 2023
Price :
$35
*
At a glance
- Drugs Isoniazid (Primary) ; Rifapentine (Primary) ; Tenofovir alafenamide (Primary) ; Pyridoxine
- Indications Hepatitis B; HIV infections; HIV-1 infections; Tuberculosis
- Focus Pharmacokinetics
- Acronyms YODA
- 22 Dec 2022 Status changed from recruiting to completed.
- 31 Mar 2022 Planned End Date changed from 30 Aug 2023 to 23 Aug 2023.
- 31 Mar 2022 Planned primary completion date changed from 30 Aug 2023 to 23 Aug 2023.